ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 67.14

Change

-1.57 (-2.28)%

Market Cap

CAD 0.26B

Volume

5.20K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-15 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.84 (-1.91%)

CAD 3.16B
ZWU:CA BMO Covered Call Utilities ETF

+0.08 (+0.73%)

CAD 1.90B
XIT:CA iShares S&P/TSX Capped Informa..

-0.23 (-0.34%)

CAD 0.69B
TXF:CA First Asset Tech Giants Covere..

-0.64 (-2.90%)

CAD 0.68B
HTA:CA Harvest Tech Achievers Growth ..

-0.53 (-2.72%)

CAD 0.64B
XHC:CA iShares Global Healthcare (CAD..

-1.39 (-1.97%)

CAD 0.60B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.06 (-0.27%)

CAD 0.56B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.01 (+0.04%)

CAD 0.36B
CWW:CA iShares Global Water Common Cl..

N/A

CAD 0.34B
COW:CA iShares Global Agriculture Com..

+0.14 (+0.21%)

CAD 0.28B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.48% 14% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.48% 11% F 14% F
Trailing 12 Months  
Capital Gain 7.32% 26% F 33% F
Dividend Return 0.81% 25% F 6% D-
Total Return 8.13% 17% F 25% F
Trailing 5 Years  
Capital Gain 17.09% 34% F 53% F
Dividend Return 2.40% 16% F 4% F
Total Return 19.49% 17% F 37% F
Average Annual (5 Year Horizon)  
Capital Gain 4.49% 31% F 51% F
Dividend Return 4.87% 26% F 48% F
Total Return 0.38% 28% F 27% F
Risk Return Profile  
Volatility (Standard Deviation) 16.29% 63% D 52% F
Risk Adjusted Return 29.90% 29% F 48% F
Market Capitalization 0.26B 71% C- 49% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.